1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131:S1.
2. Feldt B, Dion GR, Weitzel EK, McMains KC. Acute Sinusitis. South Med J 2013;106(10): 577-581
3. DeMuri GP, Wald ER. Sinusitis. In: Bennet JE, Dolin R, Blaser MJ (eds). Mandell Douglas and Bennet’s Principles and Practice of Infectious Diseases 9th ed Philadelphia; Elsevier Saunders,
2020:844-854
4. Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10 2009:1–157.
5. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015; 152:S1.
6. Wilson JF. In the clinic. Acute sinusitis. Ann Intern Med 2010; 153:ITC31.
7. Van Cauwenberge P, Sys L, De Belder T, et al. Anatomy and physiology of the nose and the paranasal sinuses. Immunol Allergy Clin North Am. 2004;24:1–17.
8. Baroody FM. Nasal and paranasal sinus anatomy and physiology. Clin Allergy Immunol. 2007;19:1–21.
9. Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev. 2001;51:5–19.
10. Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJC, Hicks LA et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis
2012;54(8): e72-e112
11. Pelton SI, Loughlin A, Marchant C, et al Indirect effects of PCV13 on nasopharyngeal colonization with Streptococcus pneumoniae vaccine serotypes achieved with 65% to 75% vaccine uptake.
IDWeek. San Diego, CA, USA; 2012.
12. Kaur R, Casey JR, Pichichero ME. Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to
the 7-valent era, 2006-2015. Pediatr Infect Dis J. 2016;35:901–906.
13. Fritz SA, Krauss MJ, Epplin EK, et al. The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J. 2011;30:349–351.
14. Bates DD, Mims JW. Invasive fungal sinusitis caused by Pseudallescheria boydii: case report and literature review. Ear Nose Throat J. 2006;85:729–737.
15. Simmons JH, Zeitler PS, Fenton LZ, et al. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and
review of the literature. Pediatr Diabetes. 2005;6:234–238.
16. Park AH, Muntz HR, Smith ME, et al. Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer. Otolaryngol Head Neck Surg. 2005;133: 411–416.
17. Gwaltney JM Jr, Hendley JO, Simon G, et al. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 1967;202:494–500.
18. Wald ER, Applegate KE, Bordley C, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132:e262–e280.
19. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:155–212.
20. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116:S13–S47.
21. Matho A, Mulqueen M, Tanino M, et al. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: a randomized clinical trial. PLoS ONE.
2018;13:e0196734.
22. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013;(2):CD005149.
OTİTİS EKSTERNA
KAYNAKLAR
1. Stone KE. Otitis externa. Pediatr Rev 2007; 28:77.
2. Pelton SI. Otitis Externa, Otitis Media, and Mastoiditis. In: Bennet JE, Dolin R, Blaser MJ (eds). Mandell Douglas and Bennet’s Principles and Practice of Infectious Diseases 9th ed Philadelp-
hia; Elsevier Saunders, 2020:835-843.
3. Schaefer P, Baugh RF. Acute otitis externa: An update Am Fam Physician. 2012;86(11):1055-1061.
4. Osguthorpe JD, Nielsen DR. Otitis externa: Review and clinical update. Am Fam Physician 2006; 74:1510.
5. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002; 112:1166.
6. Ahmad N, Etheridge C, Farrington M, Baguley DM. Prospective study of the microbiological flora of hearing aid moulds and the efficacy of current cleaning techniques. J Laryngol Otol 2007;
121:110.
7. Beers SL, Abramo TJ. Otitis externa review. Pediatr Emerg Care 2004; 20:250.
8. Rosenfeld RM, Schwartz RS, Cannon CR et al. Clinical Practice Guideline: Acute otitis externa. Otolaryngology–Head and Neck Surgery 2014;150(1S):S1–S24.
9. Llor C, McNulty CA, Butler CC. Ordering and interpreting ear swabs in otitis externa. BMJ 2014; 349:g5259.
10. Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev 2010; :CD004740.
11. Klein JO. The use of topical ofloxacin for otitic diseases in infants and children. Pediatr Infect Dis J. 2001;20:97–125.
12. Roland PS, Kreisler LS, Reese B, et al. Topical ciprofloxacin/dexamethasone otitic suspension is superior to ofloxacin otic solution in the treatment of children with otorrhea through tympa-
nostomy tubes. Pediatrics. 2004;113(1 Pt 1):e40–e46.
13. Schaefer P, Baugh RF. Acute otitis externa: An update Am Fam Physician. 2012;86(11):1055-1061.
14. Ely JE, Hansen MR, Clark EC. Diagnosis of ear pain. Am Fam Physician 2008;77(5):621-8.
15. Magliulo G, Ciniglio Appiani M. Mucoepidermoid carcinoma of the external auditory canal. Otolaryngol Head Neck Surg 2010; 142:624.
15. Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004; 4:34.
16. Takata J, Hopkins M, Alexander V, et al. Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high-quality research. Clin Otolaryngol
2023; 48:381.
17. Muraleedharan M, Keshri A, Rao RN, et al. Aspergillus infections of lateral skull base: a case series. Eur Arch Otorhinolaryngol 2024; 281:1221.
18. Acuin J. Chronic suppurative otitis media: Burden of illness and management options. World Health Organization 2004. Available at: https://apps.who.int/iris/handle/10665/42941 (Accessed
on January 03, 2023).
19. Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M. Update on otitis media: prevention and treatment. Infection and Drug Resistance 2014;7:15-24
20. Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226.
21. Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10 and LRT4 are associated with recurrent acute otitis media. Pediatrics.
2007;120:815–823.
22. Ilia S, Goulielmos GN, Samonis G, Galanakis E. Host’s response in otitis media: understanding genetic susceptibility. Pediatr Infect Dis J 2008; 27:929.
23. Prulière-Escabasse V, Coste A, Chauvin P, et al. Otologic features in children with primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg 2010; 136:1121.
24. Takeuchi K, Kitano M, Sakaida H, et al. Analysis of Otologic Features of Patients With Primary Ciliary Dyskinesia. Otol Neurotol 2017; 38:e451.
25. Coticchia JM, Chen M, Sachdeva L, Mutchnick S. New paradigms in the pathogenesis of otitis mediain children. Frontiers in Pediatrics 2013;1:52.
26. Pettigrew MM, Gent JF, Pyles RB, et al. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol 2011; 49:3750.
27. Liaw J, Saadi R, Patel VA, Isildak H. Middle Ear Viral Load Considerations in the COVID-19 Era: A Systematic Review. Otol Neurotol 2021; 42:217.
28. Vergison A. Microbiology of otitis media: A moving target. Vaccine 2008;26S:G5-G10.
29. Kaur R, Morris M, Pichichero M. Epidemiology of otitis media in the PCV era. Pediatrics. 2017;140:e20170181.
30. Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in Southern Israel shortly after sequ-
ential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014;59:1724–1732.
31. Hartnick CJ, Shott S, Willging JP, et al. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern. Arch Otolaryngol Head Neck Surg. 2000;126:1440–
1443.
32. Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani P. Otitis Media Diagnosis and Treatment Am Fam Physician. 2013;88(7):435-440.
33. American Academy of Family Physicians, American Academy of Otolaryngology—Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion.
Otitis media with effusion. Pediatrics. 2004;113:1412–1429.
34. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131:e964–e999.
35. Tahtinen PA, Laine MK, Huovinen P, et al. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364:116.